First Horizon Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.88K Buy
+667
New +$5.38K ﹤0.01% 1851
2024
Q2
Sell
-353
Closed -$5.55K 2343
2024
Q1
$5.55K Sell
353
-172
-33% -$2.66K ﹤0.01% 1788
2023
Q4
$8.49K Buy
+525
New +$8.59K ﹤0.01% 1646
2023
Q1
Sell
-101
Closed -$933 2515
2022
Q4
$933 Hold
101
﹤0.01% 2261
2022
Q3
$1K Sell
101
-46
-31% -$457 ﹤0.01% 2155
2022
Q2
$1K Buy
147
+107
+268% +$1.02K ﹤0.01% 2239
2022
Q1
$0 Sell
40
-225
-85% -$4.74K ﹤0.01% 2084
2021
Q4
$9K Hold
265
﹤0.01% 1561
2021
Q3
$13K Buy
265
+40
+18% +$1.85K ﹤0.01% 1433
2021
Q2
$10K Sell
225
-27
-11% -$1.2K ﹤0.01% 1350
2021
Q1
$12K Buy
252
+7
+3% +$364 ﹤0.01% 1240
2020
Q4
$13K Sell
245
-99
-29% -$4.47K ﹤0.01% 1009
2020
Q3
$13K Hold
344
﹤0.01% 951
2020
Q2
$11K Hold
344
﹤0.01% 981
2020
Q1
$9K Hold
344
﹤0.01% 961
2019
Q4
$10K Buy
+344
New +$8.19K ﹤0.01% 1069

Other funds holding NEO

First Horizon Advisors's NEO Position: Q2 2025 in Review

First Horizon Advisors opened a new position in NeoGenomics (NEO) in Q2 2025: 667 shares worth $4.88K. The stake represents ﹤0.01% of the portfolio and ranks #1851 among its holdings. This is a return to the name: First Horizon Advisors previously reported a position in NEO as recently as Q1 2024.

First Horizon Advisors first reported a position in NEO in Q4 2019 and has held it in 16 quarters since. The position peaked at $13K in Q3 2021. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • First Horizon Advisors held 667 shares of NeoGenomics worth $4.88K as of Q2 2025.
  • NeoGenomics was a new First Horizon Advisors position in Q2 2025.
  • NeoGenomics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1851 holding.
  • First Horizon Advisors first reported a position in NeoGenomics in Q4 2019 and has held it in 16 quarters since.
  • First Horizon Advisors's NeoGenomics position peaked at $13K in Q3 2021.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.